OpenURL Connection Search

Select item for more details and to access through your institution.

Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies.
Published in:
European Journal of Neurology, 2017, v. 24, n. 5, p. 726, doi. 10.1111/ene.13272
By:
- Havrdova, E.;
- Giovannoni, G.;
- Gold, R.;
- Fox, R. J.;
- Kappos, L.;
- Phillips, J. Theodore;
- Okwuokenye, M.;
- Marantz, J. L.
Publication type:
Article
Survey of diagnostic and treatment practices for multiple sclerosis in Europe.
Published in:
European Journal of Neurology, 2017, v. 24, n. 3, p. 516, doi. 10.1111/ene.13236
By:
- Fernández, O.;
- Delvecchio, M.;
- Edan, G.;
- Fredrikson, S.;
- Gionvannoni, G.;
- Hartung, H. ‐ P.;
- Havrdova, E.;
- Kappos, L.;
- Pozzilli, C.;
- Soerensen, P. S.;
- Tackenberg, B.;
- Vermersch, P.;
- Comi, G.
Publication type:
Article
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.
Published in:
European Journal of Neurology, 2017, v. 24, n. 2, p. 292, doi. 10.1111/ene.13200
By:
- Uher, T.;
- Vaneckova, M.;
- Sormani, M. P.;
- Krasensky, J.;
- Sobisek, L.;
- Dusankova, J. Blahova;
- Seidl, Z.;
- Havrdova, E.;
- Kalincik, T.;
- Benedict, R. H. B.;
- Horakova, D.
Publication type:
Article
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
Published in:
European Journal of Neurology, 2016, v. 23, n. 4, p. 729, doi. 10.1111/ene.12929
By:
- Spelman, T.;
- Mekhael, L.;
- Burke, T.;
- Butzkueven, H.;
- Hodgkinson, S.;
- Havrdova, E.;
- Horakova, D.;
- Duquette, P.;
- Izquierdo, G.;
- Grand'Maison, F.;
- Grammond, P.;
- Barnett, M.;
- Lechner ‐ Scott, J.;
- Alroughani, R.;
- Trojano, M.;
- Lugaresi, A.;
- Granella, F.;
- Pucci, E.;
- Vucic, S.
Publication type:
Article
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing--remitting multiple sclerosis.
Published in:
European Journal of Neurology, 2016, v. 23, p. 412, doi. 10.1111/ene.12922
By:
- Radue, E.-W.;
- Sprenger, T.;
- Vollmer, T.;
- Giovannoni, G.;
- Gold, R.;
- Havrdova, E.;
- Selmaj, K.;
- Stefoski, D.;
- You, X.;
- Elkins, J.
Publication type:
Article
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing−remitting multiple sclerosis.
Published in:
European Journal of Neurology, 2016, v. 23, n. 2, p. 412, doi. 10.1111/ene.12922
By:
- Radue, E. ‐ W.;
- Sprenger, T.;
- Vollmer, T.;
- Giovannoni, G.;
- Gold, R.;
- Havrdova, E.;
- Selmaj, K.;
- Stefoski, D.;
- You, X.;
- Elkins, J.
Publication type:
Article
'Hidden' factors influencing quality of life in patients with multiple sclerosis.
Published in:
European Journal of Neurology, 2015, v. 22, p. 28, doi. 10.1111/ene.12801
By:
- Lysandropoulos, A. P.;
- Havrdova, E.
Publication type:
Article
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
Published in:
European Journal of Neurology, 2015, v. 22, n. 7, p. 1113, doi. 10.1111/ene.12716
By:
- Uher, T.;
- Horakova, D.;
- Kalincik, T.;
- Bergsland, N.;
- Tyblova, M.;
- Ramasamy, D. P.;
- Seidl, Z.;
- Vaneckova, M.;
- Krasensky, J.;
- Havrdova, E.;
- Zivadinov, R.
Publication type:
Article
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Published in:
European Journal of Neurology, 2015, v. 22, n. 4, p. 624, doi. 10.1111/ene.12479
By:
- Tyblova, M.;
- Kalincik, T.;
- Zikan, V.;
- Havrdova, E.
Publication type:
Article
Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
Published in:
European Journal of Neurology, 2015, v. 22, n. 3, p. 570, doi. 10.1111/ene.12618
By:
- Voloshyna, N.;
- Havrdová, E.;
- Hutchinson, M.;
- Nehrych, T.;
- You, X.;
- Belachew, S.;
- Hotermans, C.;
- Paes, D.
Publication type:
Article
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.
Published in:
European Journal of Neurology, 2013, v. 20, n. 7, p. 1032, doi. 10.1111/ene.12097
By:
- Grove, R. A.;
- Shackelford, S.;
- Sopper, S.;
- Pirruccello, S.;
- Horrigan, J.;
- Havrdova, E.;
- Gold, M.;
- Graff, O.
Publication type:
Article
A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting.
Published in:
European Journal of Neurology, 2006, v. 13, n. 1, p. 61, doi. 10.1111/j.1468-1331.2006.01147.x
By:
- Karussis, D.;
- Biermann, L. D.;
- Bohlega, S.;
- Boiko, A.;
- Chofflon, M.;
- Fazekas, F.;
- Freedman, M.;
- Gebeily, S.;
- Gouider, R.;
- Havrdova, E.;
- Jakab, G.;
- Karabudak, R.;
- Miller, A.
Publication type:
Article
High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.
Published in:
Bone Marrow Transplantation, 2000, v. 25, n. 5, p. 525
By:
- Kozák, T;
- Havrdová, E;
- Pit’ha, J;
- Gregora, E;
- Pytlík, R;
- Maaloufová, J;
- Marečková, H;
- Kobylka, P;
- Vodvářková, Š
Publication type:
Article
Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.
Published in:
Multiple Sclerosis (13524585), 2006, v. 12, n. 6, p. 814, doi. 10.1177/1352458506071301
By:
- Saccardi, R.;
- Kozak, T.;
- Bocelli-Tyndall, C.;
- Fassas, A.;
- Kazis, A.;
- Havrdova, E.;
- Carreras, E.;
- Saiz, A.;
- Löwenberg, B.;
- te Boekhorst, P. A. W.;
- Gualandi, F.;
- Openshaw, H.;
- Longo, G.;
- Pagliai, F.;
- Massacesi, L.;
- Deconink, E.;
- Ouyang, J.;
- Nagore, F..J. Z.;
- Besalduch, J.;
- Lisukov, I. A.
Publication type:
Article
Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis.
Published in:
Multiple Sclerosis (13524585), 2006, v. 12, n. 2, p. 227, doi. 10.1191/135248506ms1248oa
By:
- Rasova, K.;
- Havrdova, E.;
- Brandejsky, P.;
- Zálišová, M.;
- Foubikova, B.;
- Martinkova, P.
Publication type:
Article
Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms.
Published in:
Multiple Sclerosis (13524585), 2006, v. 12, n. 1, p. 108, doi. 10.1191/135248506ms1249cr
By:
- Frohman, E. M.;
- Havrdova, E.;
- Levinson, B.;
- Slanar, O.
Publication type:
Article
Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?
Published in:
Multiple Sclerosis (13524585), 2005, v. 11, n. 2, p. 213, doi. 10.1191/1352458505ms1155oa
By:
- Rasova, K.;
- Brandejsky, P.;
- Havrdova, E.;
- Zalisova, M.;
- Rexova, P.
Publication type:
Article
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
Published in:
Genes & Immunity, 2013, v. 14, n. 4, p. 244, doi. 10.1038/gene.2013.17
By:
- Kalincik, T;
- Guttmann, C R G;
- Krasensky, J;
- Vaneckova, M;
- Lelkova, P;
- Tyblova, M;
- Seidl, Z;
- De Jager, P L;
- Havrdova, E;
- Horakova, D
Publication type:
Article
Cost of multiple sclerosis in the Czech Republic: The COMS study.
Published in:
Multiple Sclerosis Journal, 2012, v. 18, n. 5, p. 662, doi. 10.1177/1352458511424422
By:
- Blahova Dusankova, J;
- Kalincik, T;
- Dolezal, T;
- Kobelt, G;
- Havrdova, E
Publication type:
Article
Efekt cvičení jógy na subjektivní obtíže a chůzi pacientů s roztroušenou sklerózou.
Published in:
Medicina Sportiva Bohemica et Slovaca, 2023, v. 32, n. 4, p. 118
By:
- K1,2., Novotná;
- K, Michálková;
- R, Větrovská;
- E., Kubala Havrdová
Publication type:
Article
Neutralising antibodies to interferon β in multiple sclerosis.
Published in:
Journal of Neurology, 2007, v. 254, n. 7, p. 827, doi. 10.1007/s00415-006-0486-3
By:
- Hartung, H.-P.;
- Polman, C.;
- Bertolotto, A.;
- Deisenhammer, F.;
- Giovannoni, G.;
- Havrdova, E.;
- Hemmer, B.;
- Hillert, J.;
- Kappos, L.;
- Kieseier, B.;
- Killestein, J.;
- Malcus, C.;
- Comabella, M.;
- Pachner, A.;
- Schellekens, H.;
- Sellebjerg, F.;
- Selmaj, K.;
- Sorensen, P.
Publication type:
Article
Hematopoietic stem cell transplantation for multiple sclerosis : A retrospective multicenter study.
Published in:
Journal of Neurology, 2002, v. 249, n. 8, p. 1088, doi. 10.1007/s00415-002-0800-7
By:
- Fassas, A.S.;
- Passweg, J. R.;
- Anagnostopoulos, A.;
- Kazis, A.;
- Kozak, T.;
- Havrdova, E.;
- Carreras, E.;
- Graus, F.;
- Kashyap, A.;
- Openshaw, H.;
- Schipperus, M.;
- Deconinck, E.;
- Mancardi, G.;
- Marmont, A.;
- Hansz, J.;
- Rabusin, M.;
- Zuazu Nagore, F. J.;
- Besalduch, J.;
- Dentamaro, T.;
- Fouillard, L.
Publication type:
Article
Increased Serum Levels of C21 Steroids in Female Patients With Multiple Sclerosis.
Published in:
Physiological Research, 2015, v. 64, p. S247, doi. 10.33549/physiolres.933145
By:
- KANCEVA, R.;
- STÁRKA, L.;
- KANCHEVA, L.;
- HILL, M.;
- VELIKOVÁ, M.;
- HAVRDOVÁ, E.
Publication type:
Article
Bone Mineral Density and Body Composition in Men With Multiple Sclerosis Chronically Treated With Low-Dose Glucocorticoids.
Published in:
Physiological Research, 2012, v. 61, n. 4, p. 405, doi. 10.33549/physiolres.932299
By:
- Zikán, V.;
- Týblová, M.;
- Raška Jr., I.;
- Havrdová, E.;
- Luchavová, M.;
- Michalská, D.;
- Kuběna, A. A.
Publication type:
Article
Neurobiological Aspects of Depressive Disorder and Antidepressant Treatment: Role of Glia.
Published in:
Physiological Research, 2008, v. 57, n. 2, p. 151
By:
- Páv, M.;
- Kovářů, H.;
- Fišerová, A.;
- Havrdová, E.;
- Lisá, V.
Publication type:
Article
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.
Published in:
Clinical & Experimental Immunology, 2015, v. 181, n. 3, p. 385, doi. 10.1111/cei.12652
By:
- Rup, B.;
- Pallardy, M.;
- Sikkema, D.;
- Albert, T.;
- Allez, M.;
- Broet, P.;
- Carini, C.;
- Creeke, P.;
- Davidson, J.;
- De Vries, N.;
- Finco, D.;
- Fogdell‐Hahn, A.;
- Havrdova, E.;
- Hincelin‐Mery, A.;
- C. Holland, M.;
- H. Jensen, P. E.;
- Jury, E. C.;
- Kirby, H.;
- Kramer, D.;
- Lacroix‐Desmazes, S.
Publication type:
Article
Toxocara spp. seronegativity in Czech patients with early form of multiple sclerosis - clinically isolated syndrome.
Published in:
Epidemiology, Microbiology, Immunology / Epidemiologie, Mikrobiologie, Imunologie, 2017, v. 66, n. 3, p. 124
By:
- H., Posová;
- Z., Hrušková;
- E., Havrdová;
- L., Kolářová
Publication type:
Article
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.
Published in:
Journal of Neurology, 2014, v. 261, n. 4, p. 773, doi. 10.1007/s00415-014-7264-4
By:
- Vollmer, T.;
- Sorensen, P.;
- Selmaj, K.;
- Zipp, F.;
- Havrdova, E.;
- Cohen, J.;
- Sasson, N.;
- Gilgun-Sherki, Y.;
- Arnold, D.
Publication type:
Article
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis.
Published in:
Journal of Neurology, 2011, v. 258, n. 3, p. 449, doi. 10.1007/s00415-010-5777-z
By:
- MacManus, D. G.;
- Miller, D. H.;
- Kappos, L.;
- Gold, R.;
- Havrdova, E.;
- Limmroth, V.;
- Polman, C. H.;
- Schmierer, K.;
- Yousry, T. A.;
- Eraksoy, M.;
- Meluzinova, E.;
- Dufek, M.;
- Yang, M.;
- O'Neill, G. N.;
- Dawson, K.
Publication type:
Article
Positive Effect of a Cooling Cap on Functional Performance in Thermosensitive People with Multiple Sclerosis: A Randomized Controlled Trial.
Published in:
Acta Neurologica Scandinavica, 2024, v. 2024, p. 1, doi. 10.1155/2024/4882755
By:
- Novotna, K.;
- Dedinova, K.;
- Menkyova, I.;
- Uher, T.;
- Kubala Havrdova, E.;
- Angerova, Y.
Publication type:
Article
Early predictors of non-response to interferon in multiple sclerosis.
Published in:
Acta Neurologica Scandinavica, 2012, v. 126, n. 6, p. 390, doi. 10.1111/j.1600-0404.2012.01662.x
By:
- Horakova, D.;
- Kalincik, T.;
- Dolezal, O.;
- Krasensky, J.;
- Vaneckova, M.;
- Seidl, Z.;
- Havrdova, E.
Publication type:
Article
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
Published in:
European Neurology, 2012, v. 68, n. 1, p. 23, doi. 10.1159/000337683
By:
- Vaneckova, M.;
- Kalincik, T.;
- Krasensky, J.;
- Horakova, D.;
- Havrdova, E.;
- Hrebikova, T.;
- Seidl, Z.
Publication type:
Article
Anti‐inflammatory disease‐modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.
Published in:
European Journal of Neurology, 2019, v. 26, n. 2, p. 363, doi. 10.1111/ene.13824
By:
- Lorscheider, J.;
- Kuhle, J.;
- Izquierdo, G.;
- Lugaresi, A.;
- Havrdova, E.;
- Horakova, D.;
- Hupperts, R.;
- Duquette, P.;
- Girard, M.;
- Prat, A.;
- Grand'Maison, F.;
- Grammond, P.;
- Sola, P.;
- Ferraro, D.;
- Trojano, M.;
- Ramo‐Tello, C.;
- Lechner‐Scott, J.;
- Pucci, E.;
- Solaro, C.;
- Slee, M.
Publication type:
Article
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management.
Published in:
European Journal of Neurology, 2018, v. 25, n. 5, p. 1, doi. 10.1111/ene.13581
By:
- Fernández, O.;
- Delvecchio, M.;
- Edan, G.;
- Fredrikson, S.;
- Giovannoni, G.;
- Hartung, H.‐P.;
- Havrdova, E.;
- Kappos, L.;
- Pozzilli, C.;
- Soerensen, P. S.;
- Tackenberg, B.;
- Vermersch, P.;
- Comi, G.
Publication type:
Article
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
Published in:
European Journal of Neurology, 2018, v. 25, n. 2, p. 215, doi. 10.1111/ene.13536
By:
- Montalban, X.;
- Gold, R.;
- Thompson, A. J.;
- Otero‐Romero, S.;
- Amato, M. P.;
- Chandraratna, D.;
- Clanet, M.;
- Comi, G.;
- Derfuss, T.;
- Fazekas, F.;
- Hartung, H. P.;
- Havrdova, E.;
- Hemmer, B.;
- Kappos, L.;
- Liblau, R.;
- Lubetzki, C.;
- Marcus, E.;
- Miller, D. H.;
- Olsson, T.;
- Pilling, S.
Publication type:
Article
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
Published in:
Multiple Sclerosis (13524585), 2010, v. 16, n. 11, p. 1360, doi. 10.1177/1352458510378127
By:
- Comi, G.;
- Abramsky, O;
- Arbizu, T;
- Boyko, A;
- Gold, R;
- Havrdová, E;
- Komoly, S;
- Selmaj, K;
- Sharrack, B;
- Filippi, M
Publication type:
Article
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
Published in:
Multiple Sclerosis (13524585), 2009, v. 15, n. 8, p. 965, doi. 10.1177/1352458509105229
By:
- Havrdova, E.;
- Zivadinov, R.;
- Krasensky, J.;
- Dwyer, M. G.;
- Novakova, I.;
- Dolezal, O.;
- Ticha, V.;
- Dusek, L.;
- Houzvickova, E.;
- Cox, J. L.;
- Bergsland, N.;
- Hussein, S.;
- Svobodnik, A.;
- Seidl, Z.;
- Vaneckova, M.;
- Horakova, D.
Publication type:
Article
Perorální kladribin v léčbě roztroušené sklerózy - data z celostátního registru ReMuS®.
Published in:
Česká a Slovenská Neurologie a Neurochirurgie, 2021, v. 84, n. 6, p. 555
By:
- Horáková, D.;
- Vachová, M.;
- Tvaroh, A.;
- Drahota, J.;
- Mazouchová, A.;
- Mareš, J.;
- Woznicová, I.;
- Zimová, D.;
- Libertínová, J.;
- Martinková, A.;
- Recmanová, E.;
- Grunermelová, M.;
- Vališ, M.;
- Adámková, J.;
- Ampapa, R.;
- Benešová, Y.;
- Dufek, M.;
- Peterka, M.;
- Kubala Havrdová, E.
Publication type:
Article
Spektrum MR nálezů progresivní multifokální leukoencefalopatie u kohorty pa-cientů s roztroušenou sklerózou v ČR.
Published in:
Česká a Slovenská Neurologie a Neurochirurgie, 2019, v. 82, n. 4, p. 381
By:
- Vaněčková, M.;
- Martinková, A.;
- Tupý, R.;
- Fiedler, J.;
- Štětkářová, I.;
- Medová, E.;
- Vachová, M.;
- Marková, J.;
- Grunermelová, M.;
- Meluzínová, E.;
- Adámková, J.;
- Kubále, J.;
- Talábová, M.;
- Horáková, D.;
- Kubala Havrdová, E.
Publication type:
Article
Fingolimod v reálné klinické praxi.
Published in:
Česká a Slovenská Neurologie a Neurochirurgie, 2017, v. 80, n. 2, p. 213, doi. 10.14735/amcsnn2017213
By:
- Tichá, V.;
- Sobíšek, L.;
- Havrdová, E.
Publication type:
Article
Myxovirus resistance protein A v terapii interferony-β u pacientů s roztroušenou sklerózou a algoritmus sledování účinnosti léčby.
Published in:
Česká a Slovenská Neurologie a Neurochirurgie, 2016, v. 79, n. 5, p. 547
By:
- Libertínová, J.;
- Meluzínová, E.;
- Havrdová, E.;
- Horáková, D.;
- Kovářová, I.;
- Hynčicová, E.;
- Lišková, P.;
- Houžvičková, E.;
- Maťoška, V.;
- Zajac, M.;
- Tomek, A.;
- Bojar, M.;
- Marusič, P.
Publication type:
Article
Pilotní studie využitelnosti nového programu pro kognitivní rehabilitaci osob s roztroušenou sklerózou.
Published in:
Rehabilitation & Physical Medicine / Rehabilitace a Fyzikální Lékařství, 2018, v. 25, n. 3, p. 131
By:
- Novotná, K.;
- Janatová, M.;
- Kadrnožková, L.;
- Holeňová, M.;
- Motýl, J.;
- Horáková, D.;
- Kubala Havrdová, E.
Publication type:
Article
Is it possible to actively and purposely make use of plasticity and adaptability in the neurorehabilitation treatment of multiple sclerosis patients? A pilot project.
Published in:
Clinical Rehabilitation, 2005, v. 19, n. 2, p. 170, doi. 10.1191/0269215505cr831oa
By:
- Rasova, K.;
- Krasensky, J.;
- Havrdova, E.;
- Obenberger, J.;
- Seidel, Z.;
- Dolezal, O.;
- Rexova, P.;
- Zalisova, M.
Publication type:
Article

Found: 43